• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Carbapenem-resistant Pseudomonas aeruginosa in intensive care units increase mortality as an emerging global threat.

作者信息

Saravanan Muthupandian, Belete Melaku A, Arockiaraj Jesu

机构信息

AMR and Nanotherapeutics Laboratory, Department of Pharmacology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS).

Department of Medical Laboratory Science, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.

出版信息

Int J Surg. 2023 Apr 1;109(4):1034-1036. doi: 10.1097/JS9.0000000000000184.

DOI:10.1097/JS9.0000000000000184
PMID:36999801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10389632/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10389632/bfafe5292c45/js9-109-1034-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10389632/bfafe5292c45/js9-109-1034-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10389632/bfafe5292c45/js9-109-1034-g001.jpg

相似文献

1
Carbapenem-resistant Pseudomonas aeruginosa in intensive care units increase mortality as an emerging global threat.重症监护病房中耐碳青霉烯类铜绿假单胞菌作为一种新出现的全球威胁，会增加死亡率。
Int J Surg. 2023 Apr 1;109(4):1034-1036. doi: 10.1097/JS9.0000000000000184.
2
Impact of carbapenem restriction on the antimicrobial susceptibility pattern of Pseudomonas aeruginosa isolates in the ICU.碳青霉烯类药物限制对 ICU 分离的铜绿假单胞菌抗菌药物敏感性模式的影响。
J Antimicrob Chemother. 2017 Nov 1;72(11):3187-3190. doi: 10.1093/jac/dkx273.
3
Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.在耐碳青霉烯类铜绿假单胞菌高流行率背景下，多重耐药不动杆菌属菌株中碳青霉烯类药物的敏感性稳定率。
Int J Antimicrob Agents. 2007 Aug;30(2):187-9. doi: 10.1016/j.ijantimicag.2007.03.001. Epub 2007 Apr 23.
4
The quick loss of carbapenem susceptibility in Pseudomonas aeruginosa at intensive care units.重症监护病房中铜绿假单胞菌对碳青霉烯类药物敏感性的快速丧失。
Int J Clin Pharm. 2018 Feb;40(1):175-182. doi: 10.1007/s11096-017-0524-5. Epub 2017 Nov 14.
5
Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa.22家大学教学医院碳青霉烯类抗生素限制措施与碳青霉烯类抗生素使用及耐碳青霉烯类铜绿假单胞菌的关系
Antimicrob Agents Chemother. 2009 May;53(5):1983-6. doi: 10.1128/AAC.01535-08. Epub 2009 Mar 9.
6
Does ertepenem alter the susceptibility of Pseudomonas aeruginosa to carbapenems?厄他培南是否会改变铜绿假单胞菌对碳青霉烯类药物的敏感性？
J Chemother. 2011 Aug;23(4):216-20. doi: 10.1179/joc.2011.23.4.216.
7
Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Microbiologic Treatment Failure.耐碳青霉烯类铜绿假单胞菌血症：死亡率及微生物治疗失败的危险因素
Antimicrob Agents Chemother. 2016 Dec 27;61(1). doi: 10.1128/AAC.01243-16. Print 2017 Jan.
8
Risk Factors for Carbapenem-resistant Pseudomonas aeruginosa Infection in Children: Correspondence.儿童耐碳青霉烯类铜绿假单胞菌感染的危险因素：通信
Pediatr Infect Dis J. 2023 Jun 1;42(6):e220-e221. doi: 10.1097/INF.0000000000003886. Epub 2023 Feb 22.
9
Associations between carbapenem use, carbapenem-resistant Pseudomonas aeruginosa, and carbapenem-resistant Acinetobacter baumannii.碳青霉烯类药物使用、耐碳青霉烯类铜绿假单胞菌和耐碳青霉烯类鲍曼不动杆菌之间的关联。
Infect Control Hosp Epidemiol. 2013 Nov;34(11):1235-7. doi: 10.1086/673460.
10
Carbapenem-Nonsusceptible Isolates from Intensive Care Units in the United States: a Potential Role for New β-Lactam Combination Agents.美国重症监护病房的耐碳青霉烯类分离株：新型β-内酰胺联合制剂的潜在作用。
J Clin Microbiol. 2019 Jul 26;57(8). doi: 10.1128/JCM.00535-19. Print 2019 Aug.

引用本文的文献

1
Predicting carbapenem-resistant Pseudomonas aeruginosa infection risk using XGBoost model and explainability.使用XGBoost模型及可解释性预测耐碳青霉烯类铜绿假单胞菌感染风险
Sci Rep. 2025 Jun 5;15(1):19737. doi: 10.1038/s41598-025-04028-x.
2
Genomic insights into -positive carbapenem-resistant in China.中国产超广谱β-内酰胺酶的碳青霉烯类耐药肠杆菌科细菌的基因组学见解
Front Microbiol. 2025 May 9;16:1546662. doi: 10.3389/fmicb.2025.1546662. eCollection 2025.
3
Mortality and exacerbations in bronchiectasis patients with carbapenem-resistant Pseudomonas aeruginosa isolation: a long-term retrospective cohort study.
分离出耐碳青霉烯类铜绿假单胞菌的支气管扩张症患者的死亡率和病情加重情况：一项长期回顾性队列研究
Ann Clin Microbiol Antimicrob. 2025 May 6;24(1):30. doi: 10.1186/s12941-025-00798-4.
4
A Comprehensive Overview of Antibacterial Agents for Combating Multidrug-Resistant Bacteria: The Current Landscape, Development, Future Opportunities, and Challenges.对抗多重耐药菌的抗菌药物综合概述：现状、发展、未来机遇与挑战
Antibiotics (Basel). 2025 Feb 21;14(3):221. doi: 10.3390/antibiotics14030221.
5
Evaluated gene expressions of Metallo beta lactamase genes GIM and , VIM, SPM in Pseudomonas aeruginosa clinical isolates.评估铜绿假单胞菌临床分离株中金属β-内酰胺酶基因GIM、VIM、SPM的基因表达。
Mol Biol Rep. 2023 Dec;50(12):10111-10120. doi: 10.1007/s11033-023-08883-7. Epub 2023 Nov 2.